Skip to main content Accessibility help
×
Home
Hostname: page-component-dc8c957cd-wvcbk Total loading time: 0.376 Render date: 2022-01-27T15:59:13.182Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Altered Immune Function In Autism

Published online by Cambridge University Press:  07 November 2014

Abstract

Recent studies of the pathogenesis of autism have suggested that this disorder may have an autoimmune basis in some patients. Observations have been made regarding cellular and humoral immune dysfunction, abnormalities associated with the complement system and major histocompatibility complex gene expression, differences in soluble mediators of the immune response, and the presence of antibrain and antimyelin autoantibodies. In this article, we review these experimental and clinical observations, and examine preliminary efforts using immunomodulatory therapies to treat autism.

Type
Feature Article
Copyright
Copyright © Cambridge University Press 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:6671.Google ScholarPubMed
2.Kanner, L. Autistic disturbances of affective contact. Nerv. Child. 1943;2:217250.Google Scholar
3.Asperger, H. Die autistischen psychopathen in kindersalter. Archiv fur Psychiatrie und Nervenkrankheiten. 1944;117:76136.CrossRefGoogle Scholar
4.Volkmar, FR, Klin, A, Siegal, B, et al. Field trial for autistic disorder in DSM-IV. Am J Psychiatry. 1994;151:13611367.Google ScholarPubMed
5.Cook, E, Leventhal, B. Autistic disorders and other pervasive developmental disorders. Psychiatr Clin North Am. 1995;4:381399.Google Scholar
6.Singh, VK, Fudenberg, HH, Emerson, D, Coleman, M. Immunodiagnosis and immunotherapy in autistic children. Ann NY Acad Sci. 1988;540:602604.CrossRefGoogle ScholarPubMed
7.Singh, VK, Warren, RP, Odell, JD, Cole, P. Changes of soluble IL-2,IL-2R, T8 antigen and IL-1 in the serum of autistic children. Clin Immunol Immunopathol. 1991;61:448455.CrossRefGoogle ScholarPubMed
8.Singh, VK, Warren, RP, Odell, JD, Warren, WL, Cole, P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993;7:97103.CrossRefGoogle ScholarPubMed
9.Warren, RP, Foster, A, Margaretten, NC, Pace, NC. Immune abnormalities in patients with autism. J Autism Dev Disord. 1986;16:189197.CrossRefGoogle ScholarPubMed
10.Warren, RP, Foster, A, Margaretten, NC. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry. 1987;26:333335.CrossRefGoogle ScholarPubMed
11.Warren, RP, Singh, VK, Cole, P, et al. Increased frequency of the null allele at the complement C4B locus in autism. Clin Exp Immunol. 1991;83:438440.CrossRefGoogle ScholarPubMed
12.Warren, RP, Yonk, LJ, Burger, RA, et al. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest. 1990;19:245251.CrossRefGoogle ScholarPubMed
13.Weizman, A, Weizman, R, Szekely, GA, Wijsenbeek, H, Livini, E. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psychiatry. 1982;7:14621465.Google Scholar
14.Yonk, LJ, Warren, RP, Burger, RA, et al. CD 4 and helper T cell depression in autism. Immunol Lett. 1990;25:341346.CrossRefGoogle Scholar
15.Gupta, S, Aggarwal, S, Heads, C. Brief report: dysregulated immune system in children with autism; beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996;26:439452.CrossRefGoogle Scholar
16.Zimmerman, A, Frye, VH, Potter, NT. Immunological aspects of autism. Internat J Ped. 1993;8:199204.Google Scholar
17.Money, J, Bobrow, NA, Clarke, FC, et al. Autism and autoimmune disease: a family study. J Autism Child Schizophr. 1971;1:146160.CrossRefGoogle Scholar
18.Chess, S. Autism in children with congential rubella. J Autism Child Schizophr. 1971;1:3347.CrossRefGoogle Scholar
19.Desmond, MM, Wilson, GS, Melnick, JL, et al. Congenital rubella encephalitis — course and early sequelae. J Pediatr. 1967;71:311331.CrossRefGoogle ScholarPubMed
20.Knobloch, H, Pasamanick, B. Gesell and Amatruda's Developmental Diagnosis. 3rd ed. New York, NY: Harper & Row; 1974:320339.Google Scholar
21.Stubbs, EG, Ash, E, Williams, CPS. Autistic and congenital cytomegalovirus. J Autism Dev Disord. 1984;14:183189.CrossRefGoogle ScholarPubMed
22.Peterson, MR, Torrey, EF. Viruses and other infectious agents as behavioral teratogens. In: Coleman, M, ed. The Autistic Syndromes. New York, NY: American Elsevier; 1976:2342.Google Scholar
23.Stubbs, EG. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr. 1976;6:269274.CrossRefGoogle Scholar
24.Sells, CJ, Carpenter, RL, Ray, CG. Sequelae of central nervous system enterovirus infection. N Engl J Med. 1975;293:14.CrossRefGoogle Scholar
25.Deykin, EY, MacMahon, B. Viral exposure and autism. Am J Epidemiol. 1979;109:628638.CrossRefGoogle ScholarPubMed
26.Roitt, I. Essential Immunology. Oxford, England: Blackwell Scientific Publications; 1991:28–29,32,129–139,325329.Google Scholar
27.Stubbs, EG, Crawford, ML. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr. 1977;7:4955.CrossRefGoogle ScholarPubMed
28.Ferrari, P, Marescot, M, Moulias, R, et al. Et at immunitaire dans l'autisme infantile. Encephale. 1988;14:339344.Google Scholar
29.Plioplys, AV, Greaves, A, Kazemi, K, Silverman, E. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology. 1994;7:1216.CrossRefGoogle Scholar
30.Morimoto, C, Hafler, DA, Weiner, HL, et al. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. N Engl J Med. 1987;316:6772.CrossRefGoogle ScholarPubMed
31.Denney, DR, Frei, BW, Gaffney, GR. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996;26:8797.CrossRefGoogle ScholarPubMed
32.Goto, M, Tanimoto, K, Chihara, T, Horiuchi, Y. Natural killer cell mediated cytotoxicity in Sjogren's syndrome and rheumatoid arthritis. Arthritis Rheum. 1981;24:13771382.CrossRefGoogle ScholarPubMed
33.Goto, M, Tanimoto, K, Horiuchi, Y. Natural killer cell mediated cytotoxicity in systemic lupus erythematosus. Arthritis Rheum. 1980;23:12741281.CrossRefGoogle ScholarPubMed
34.Walisman, BH. Current trends in multiple sclerosis research. Immunol Today. 1981;2:8793.Google Scholar
35.Ritvo, ER, Yuwiler, A, Geller, E, Ornitz, EM, Saeger, K, Plotkin, S. Increased blood serotonin and platelets in early infantile autism. Arch Gen Psychiatry. 1970;42:129133.Google Scholar
36.Wright, HH, Abramson, RK, Self, S, Genco, P, Cuccaro, M. Serotonin may affect lymphocyte cell surface markers in autistic probands. Presented at the American Academy of Child and Adolescent Psychiatry; 1990; San Francisco, Calif. NR Abstract 12.Google Scholar
37.Dawson, CA, Lineham, JH. Biogenic amines. In: Lenfant, C, Masarro, D, eds. Lung Biology in Health and Disease, Lung Cell Biology. Vol. 41. New York, NY: Marcel Dekker; 1989:1091.Google Scholar
38.Jackson, JC, Cross, RJ, Walker, F, Markesbery, WR, Brooks, WH, Roszman, TL. Influence of serotonin on the immune responses. Immunology. 1985;54:505.Google Scholar
39.Laberge, S, Cruikshank, WW, Beer, DJ, Center, DM. Secretion of IL-6 from serotonin-stimulated CD8+ T cells in vitro. J Immunol. 1996:156:310315.Google Scholar
40.Husby, G, van de Rijn, I, Zabriskie, JB, Abdin, ZH, Williams, RC Jr. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;144:10941110.CrossRefGoogle ScholarPubMed
41.Plioplys, AV, Greaves, A, Yoshida, W. Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics. 1989;20:92102.CrossRefGoogle ScholarPubMed
42.Todd, RD, Ciaranello, RD. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl head Sci USA. 1985;82:612616.CrossRefGoogle ScholarPubMed
43.Yuwiler, A, Shih, JS, Chen, CH, et al. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. J Autism Dev Disord. 1992;22:3345.CrossRefGoogle ScholarPubMed
44.Cook, EH, Perry, BD, Dawson, G, Wainwright, MS, Leventhal, BL, et al. Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects. J Autism Dev Disord. 1993;23:6778.CrossRefGoogle Scholar
45.Warren, RP, Cole, P, Odell, JD, et al. Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry. 1990;29:873877.CrossRefGoogle Scholar
46.Gillberg, IC, Gillberg, C, Kopp, , et al. Hypothyroidism and autism spectrum disorders. J Child Psychol Psychiatiatry. 1992;33:531542.CrossRefGoogle Scholar
47.Plioplys, AV, Greaves, , Kazemi, K, Silverman, E. Autism: anti-210K neurofilament immunoglobulin reactivity. Neurology. 1989;39(suppl 1):187.Google Scholar
48.Bauman, ML, Kemper, TL. Limbic and cerebellar abnormalities: consistent findings in infantile autism. J Neuropathol Exp Neurol. 1988;47:369.Google Scholar
49.ML, Bauman. Microscopic neuroanatomic abnormalities in autism. Pediatrics. 1991;87:791796.Google Scholar
50.Todd, JA, Acha-Orbea, H, Bell, JT, et al. A molecular basis for MHC Class II-associated autoimmunity. Science. 1988;240:10031009.CrossRefGoogle Scholar
51.Stubbs, EG, Ritvo, ER, Mason-Brothers, A. Autism and shared parental HLA antigens. J Am Acad Child Adolesc Psychiatry. 1985;24:182185.CrossRefGoogle Scholar
52.Taylor, C, Faulk, WP. Prevention of recurrent abortions with leukocyte transfusion. Lancet. 1981;2:6870.CrossRefGoogle Scholar
53.Redman, CWG. Immunological aspects of eclampsia and pre-eclampsia. In: Hearn, JP, ed. Immunological Aspects of Reproduction and Fertility Control. Lancaster, UK: MTP Press; 1980:5255.Google Scholar
54.Warren, RP, Singh, VK, Cole, P, et al. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics. 1992;36:203207.CrossRefGoogle Scholar
55.Warren, RP, Odell, JD, Warren, WL, et al. Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J Autism Dev Disord. 1997;27:187192.CrossRefGoogle Scholar
56.Moreno, H, Brijas, L, Arrilta, A, et al. Heterogeneidad clinica del sindrome autista: un estudio en sesenta familias. Invest Clin. 1992;33:1331.Google Scholar
57.Suzuki, M, Nakazima, K, Sugiyama, A, Nakashita, Y, Ogawa, T, et al. On the effects of pentoxifylline upon the EEG activity of early infantile autism: quantitative pharmaco-electroen-cephalographic study. Brain Dev. 1984;6:156.Google Scholar
58.Selman, K, Reine, CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988;23:339346.CrossRefGoogle Scholar
59.Brosnan, CF, Selmaj, K, Raines, CS. Hypothesis: a role for TNF in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol. 1988;18:8794.CrossRefGoogle Scholar
60.Natal, S, Louboutin, JP, Chabannes, D, et al. Pentoxifylline inhibits experimental allergic encephalitis. Acta Neurol Scand. 1993;88:9799.Google Scholar
61.Black, RS, Barclay, LL, Nolan, KA. Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc. 1992;40:237244.CrossRefGoogle ScholarPubMed
62.Sogame, S. On our experience in using pentoxifylline for abnormal behavior and the autistic syndrome. Japanese Journal of Child Psychiatry. 1978;19:134144.Google Scholar
63.Nakane, A. Effect of pentoxifylline on autistic children. Tokyoto Eisei Gakkashi. 1980;64:104105.Google Scholar
64.Shimoide, M. Effect of pentoxifylline on infantile autism. Clin Exp Med. 1981;58:285288.Google Scholar
65.Turek, S. Treatment of psychotic and autistic children with pentoxifylline. ASANA. 1981;1:5160.Google Scholar
66.Dwyer, JM. Manipulating the immune system with immunoglobulin. N Engl J Med. 1992;326:41044109.Google Scholar
67.Nevsimalova, S, Tauberova, A, Doutlik, S, Kucera, V, Dlouha, O. A role for autoimmunity in the etiopathogenesis of Landau-Kleffner Syndrome? Brain Dev. 1992;14:342345.CrossRefGoogle Scholar
68.Cole, AJ, Andermann, F, Taylor, L, et al. The Landau-Kleffner syndrome of acquired epileptic aphasia: unusual clinical outcome, surgical experience, and absence of encephalitis. Neurology. 1988;38:3138.CrossRefGoogle ScholarPubMed
69.Tuchman, RF. Epilepsy, language and behavior: clinical models in childhood. J Child Neurol. 1994;9:95102.CrossRefGoogle ScholarPubMed
70.Paquier, PF, Van Dongen, HR, Loonen, CB. The Landau-Kleffner syndrome or acquired aphasia with convusive disorder. Arch Neurol. 1992;49:354359.CrossRefGoogle ScholarPubMed
5
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Altered Immune Function In Autism
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Altered Immune Function In Autism
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Altered Immune Function In Autism
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *